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(TAMMV)
(Transcranial Doppler - TCD)
(Magnetic Resonance Imaging - MRI) 
Stroke (and SCI)
High Risk – TAMMV ≥ 200 cm/s
Conditional – 170 cm/s < TAMMV < 200 cm/s
Normal – TAMMV < 170 cm/s
Sources (images): WikiCommons Licenses  
PUTATIVE GENETIC MODULATORS OF PEDIATRIC STROKE IN SCA
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• PCR, Gap-PCR, PCR –RFLP, ARMS, FFLA
• Sanger sequencing
• Next-generation sequencing
• LR-PCR (FailSafe – Epicentre)
• Nextera XT® (Illumina)
• MiSeq® (Illumina)
• MiSeq® Reporter; BW; GATK; FastQC; IGV; VEP
• R v. and SPSS v.24 (2 and Fisher; Bonferroni c.)





• 70 pediatric SCA patients (age ≥ 3 years)
• Cerebral vasculopathy - 3 main groups:
 Stroke: ≥ 1 stroke event
 Risk: abnormal TCD and or MRI scan results
Normal: no history of abnormalities in TCD or MRI scans
• Database with clinical, imaging and laboratory data
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NOS3
(promoter) rs2070744_C [p=0.019 ; OR=6.700 (CI: 1.081 – 73.323)
intron 4 VNTR 27 bp (=4 repeats) [p=0.020 ; OR=2.710 (CI:1.088-7.088)]Risk
Stroke
VCAM1 (promoter)
rs1409419_T [p=0.008 ; OR=4.330 (CI: 1.391-14.259)]Stroke
ITGA4
rs113276800_C [p=0.021; OR=9.714 (CI: 1.479-63.806)]
rs74850478_A [p=0.035; OR=13.125 (CI:1.203-143.233)]
rs3770138_C [p=0.042; OR=6.286 (CI:1.143-34.570)]
rs3770138_C    [p=0.045; OR=6.176 (CI:1.126-33.876)]
rs1375493_G  [p=0.050; OR=8.750 (CI: 0.993-2.992)]
rs35723031_GA [p=0.050; OR=8.75 (CI: 0.99-2.99)]
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POTENTIAL MODULATION OF PEDIATRIC STROKE IN SCA
VCAM1 variant
• Altered TF binding site (position -1592)
(RXRF→PRDF and FHXB loss)
• Increased VCAM1 inducible expression
ENDOTHELIAL DYSFUNCTION
ITGA4 variants
• Altered enhancers/silencers  expression
• Increased cell adhesion to activated 
endothelium
CELL – ENDOTHELIAL ADHESION
VASCULOPATHY
NOS3 variants
• Decreased NO bio-availability
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biological link between the VCAM-1 and
ITGA4 variants with cerebral vasculopathy
In vitro functional studies
VCAM1 and ITGA4 – potential therapeutic targets
Gene panel (NGS) (diagnostic/prognostic)
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